Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 16, 2018Applied NanoscienceOpen Access

The use of nanotechnology in cardiovascular disease

View Full Paper
Ask AI
Bookmark
Share

Authors

MCMeera ChandaranaACA. D. M. CurtisKeele UniversityCHClare HoskinsUniversity of Strathclyde

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chandarana et al. (2018) studied this question.

synapsesocial.com/papers/6a15faa04718e7db3a52464bhttps://doi.org/10.1007/s13204-018-0856-z
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Efficient drug delivery to atherosclerotic lesions and the antiatherosclerotic effect by dexamethasone incorporated into liposomes in atherogenic mice2005 · 69 citations
  2. 2Dendrimers as drug delivery vehicles: non‐covalent interactions of bioactive compounds with dendrimers2007 · 146 citations
  3. 3Nanoparticles for Cardiovascular Imaging and Therapeutic Delivery, Part 1: Compositions and Features2015 · 40 citations
  4. 4Application of Nanoparticle Technologies in the Combat against Anti-Microbial Resistance2018 · 136 citations
  5. 5Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging2007 · 496 citations